Comment by ancorevard

Nonsense. Pharma will greatly benefit from the increase in number of schizophrenia patients.

Cannabis is a well established trigger among people whose genes are latent for schizophrenia or other psychosis.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604190/